160 related articles for article (PubMed ID: 25216545)
21. Antimicrobial activity of beta-lactam antibiotics against clinical pathogens after molecular inclusion in several cyclodextrins. A novel approach to bacterial resistance.
Athanassiou G; Michaleas S; Lada-Chitiroglou E; Tsitsa T; Antoniadou-Vyza E
J Pharm Pharmacol; 2003 Mar; 55(3):291-300. PubMed ID: 12724033
[TBL] [Abstract][Full Text] [Related]
22. The scourge of antibiotic resistance: the important role of the environment.
Finley RL; Collignon P; Larsson DG; McEwen SA; Li XZ; Gaze WH; Reid-Smith R; Timinouni M; Graham DW; Topp E
Clin Infect Dis; 2013 Sep; 57(5):704-10. PubMed ID: 23723195
[TBL] [Abstract][Full Text] [Related]
23. [Evolution of bacterial resistance to antibiotics in México, 1973-2013].
Rodríguez-Noriega E; León-Garnica G; Petersen-Morfín S; Pérez-Gómez HR; González-Díaz E; Morfín-Otero R
Biomedica; 2014 Apr; 34 Suppl 1():181-90. PubMed ID: 24968050
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.
Blomberg B; Mwakagile DS; Urassa WK; Maselle SY; Mashurano M; Digranes A; Harthug S; Langeland N
BMC Public Health; 2004 Oct; 4():45. PubMed ID: 15476559
[TBL] [Abstract][Full Text] [Related]
25. Combating antimicrobial resistance: antimicrobial stewardship program in Taiwan.
Tseng SH; Lee CM; Lin TY; Chang SC; Chuang YC; Yen MY; Hwang KP; Leu HS; Yen CC; Chang FY
J Microbiol Immunol Infect; 2012 Apr; 45(2):79-89. PubMed ID: 22483434
[TBL] [Abstract][Full Text] [Related]
26. Antibiotic resistance in animals.
Barton MD; Pratt R; Hart WS
Commun Dis Intell Q Rep; 2003; 27 Suppl():S121-6. PubMed ID: 12807287
[TBL] [Abstract][Full Text] [Related]
27. Fifteen years of surveillance by the Australian Group for Antimicrobial Resistance (AGAR).
Nimmo GR; Bell JM; Collignon PJ;
Commun Dis Intell Q Rep; 2003; 27 Suppl():S47-54. PubMed ID: 12807274
[TBL] [Abstract][Full Text] [Related]
28. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).
Rhomberg PR; Jones RN
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):414-26. PubMed ID: 19833471
[TBL] [Abstract][Full Text] [Related]
29. A review of antimicrobial resistance in Canada.
Blondeau JM; Vaughan D
Can J Microbiol; 2000 Oct; 46(10):867-77. PubMed ID: 11068672
[TBL] [Abstract][Full Text] [Related]
30. [Epidemiological overview of antibiotic resistance in France and worldwide].
Arlet G
Rev Prat; 2012 Sep; 62(7):962-7. PubMed ID: 23236869
[TBL] [Abstract][Full Text] [Related]
31. Microbiologic isolates and risk factors associated with antimicrobial resistance in patients admitted to the intensive care unit in a tertiary care hospital.
da Silva Winter J; Dos Santos RP; de Azambuja AZ; Cechinel AB; Goldani LZ
Am J Infect Control; 2013 Sep; 41(9):846-8. PubMed ID: 23422231
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance in internal medicine wards.
Menichetti F; Tagliaferri E
Intern Emerg Med; 2012 Oct; 7 Suppl 3():S271-81. PubMed ID: 23073868
[TBL] [Abstract][Full Text] [Related]
33. [Antibiotic resistance: measures urgently needed].
Kluytmans J; Vandenbroucke-Grauls C; van der Meer JW
Ned Tijdschr Geneeskd; 2010; 154():A2261. PubMed ID: 20858324
[TBL] [Abstract][Full Text] [Related]
34. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
[TBL] [Abstract][Full Text] [Related]
35. Insights into antibiotic resistance through metagenomic approaches.
Schmieder R; Edwards R
Future Microbiol; 2012 Jan; 7(1):73-89. PubMed ID: 22191448
[TBL] [Abstract][Full Text] [Related]
36. Developing a hybrid antimicrobial resistance surveillance system in India: Needs & challenges.
Kaur J; Sharma A; Dhama AS; Buttolia H; Ohri VC; Walia K; Sharma AK; Yahara K; Ahmad R; Singh H
Indian J Med Res; 2019 Feb; 149(2):299-302. PubMed ID: 31219099
[TBL] [Abstract][Full Text] [Related]
37. European recommendations for antimicrobial resistance surveillance.
Cornaglia G; Hryniewicz W; Jarlier V; Kahlmeter G; Mittermayer H; Stratchounski L; Baquero F;
Clin Microbiol Infect; 2004 Apr; 10(4):349-83. PubMed ID: 15059129
[TBL] [Abstract][Full Text] [Related]
38. Better control of antibiotic resistance.
Guillemot D; Courvalin P;
Clin Infect Dis; 2001 Aug; 33(4):542-7. PubMed ID: 11462192
[TBL] [Abstract][Full Text] [Related]
39. New developments in carbapenems.
Kattan JN; Villegas MV; Quinn JP
Clin Microbiol Infect; 2008 Dec; 14(12):1102-11. PubMed ID: 19076841
[TBL] [Abstract][Full Text] [Related]
40. Optimal use of antibiotic resistance surveillance systems.
Critchley IA; Karlowsky JA
Clin Microbiol Infect; 2004 Jun; 10(6):502-11. PubMed ID: 15191377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
